The University of Osaka Clinical Audit Committee
The University of Osaka established the Clinical Audit Committee in order to systematically review management of clinical safety at the University of Osaka Hospital from a neutral and objective perspective and provide advice for taking necessary corrective measures.
NAme | current Occupation | Reasons For Selection |
|---|---|---|
KURACHI Hirohisa (Chairman) | Director, Osaka Women's and Children's Hospital | He is familiar with both medical care and hospital management as director at the Osaka Women's and Children's Hospital. |
HASHIMOTO Shigeatsu | Professor, Diabetes/Endocrinology and Metabolism/Kidney Science Course, Fukushima Medical University Aizu Medical Center Director, Medical Safety Management Division, Fukushima Medical University Aizu Medical Center Hospital | He serves as Director of the Medical Safety Management Division, Fukushima Medical University Aizu Medical Center Hospital as an expert in medical safety management. |
MIZUSHIMA Sachiko | Director, Mizushima Law Office | She works at the Mizushima Law Office as a legal expert experienced in medical care. |
HASHIMOTO Sayoko | Director, Consumer Organization for Medicine & Law (COML) | From her activities to enhance communication abilities of patients and medical staff at COML, she can provide advice on medical care from the patient's perspective. |
TAKADA Yukinori | Director, National University Corporation Osaka University | He is engaged in risk management at the University of Osaka. |
- Report of the Clinical Audit Committee for 2017
- Report of the Clinical Audit Committee for 2018
- Report of the Clinical Audit Committee for 2019
- Report of the Clinical Audit Committee for 2020
- Report of the Clinical Audit Committee for 2021
- Report of the Clinical Audit Committee for 2022
- Report of the Clinical Audit Committee for 2023
- Report of the Clinical Audit Committee for 2024
- Report of the Clinical Audit Committee for 2025